Medtronic MDT Business Segments
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Cardiovascular | $13.98B+3.4% | $13.51B+3.2% | $13.09B+2.6% | $12.76B+2.2% | $12.48B+1.7% | |
| Diabetes | $3.11B+3.7% | $3B+3.5% | $2.9B+2.5% | $2.83B+2.7% | $2.76B+2.6% | |
| Medical Surgical | $8.81B+2.0% | $8.64B+1.2% | $8.54B+0.5% | $8.49B+1.0% | $8.41B+0.2% | |
| Neuroscience | $10.29B+1.3% | $10.16B+1.0% | $10.06B+1.1% | $9.95B+1.0% | $9.85B+0.8% | |
| Other Operating Segments | $135M-0.4% | $135.5M-0.4% | $136M-0.4% | $136.5M-0.4% | $137M-13.3% | |
| Net Sales by Geography | ||||||
| Ireland | $143M+6.7% | $134M+6.3% | $126M+5.0% | $120M+2.6% | $117M+2.6% | |
| Rest of world | $18.12B+3.1% | $17.57B+2.7% | $17.11B+2.0% | $16.77B+3.2% | $16.25B+0.8% | |
| United States | $18.1B+1.8% | $17.78B+1.5% | $17.52B+1.2% | $17.31B+0.8% | $17.17B+1.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Medtronic break its business down?
- Medtronic (MDT) reports net sales by business across 6 parts — Cardiovascular, Diabetes, Medical Surgical, Neuroscience and Other operating segment. Each is extracted from the segment footnotes and tracked over time.
- Where does Medtronic's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Medtronic's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
